Cargando…
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs
New strategies providing protection against tuberculosis (TB) are still pending. The airborne nature of Mycobacterium tuberculosis (M.tb) infection assumes that the mucosal delivery of the TB vaccine could be a more promising strategy than the systemic route of immunization. We developed a mucosal T...
Autores principales: | Sergeeva, Mariia, Romanovskaya-Romanko, Ekaterina, Zabolotnyh, Natalia, Pulkina, Anastasia, Vasilyev, Kirill, Shurigina, Anna Polina, Buzitskaya, Janna, Zabrodskaya, Yana, Fadeev, Artem, Vasin, Andrey, Vinogradova, Tatiana I., Stukova, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073308/ https://www.ncbi.nlm.nih.gov/pubmed/33923548 http://dx.doi.org/10.3390/vaccines9040394 |
Ejemplares similares
-
Enhancement of the Local CD8(+) T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
por: Vasilyev, Kirill, et al.
Publicado: (2021) -
Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens
por: Stosman, Kira I., et al.
Publicado: (2023) -
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice
por: Pulkina, Anastasia, et al.
Publicado: (2023) -
Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter
por: Sergeeva, M. V., et al.
Publicado: (2022) -
IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses
por: Plotnikova, Marina, et al.
Publicado: (2021)